Process View
A necrotic cell death process that results from the activation of endogenous cellular processes, such as signaling involving death domain receptors or Toll-like receptors.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "programmed necrotic cell death"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 1.000 | Mouse | |
BIRC3 | baculoviral IAP repeat containing 3 | 1.000 | ||
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 1.000 | ||
FADD | Fas (TNFRSF6)-associated via death domain | 1.000 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.994 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.994 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.993 | ||
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.993 | ||
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.985 | Human | |
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.981 | Human | |
BIRC2 | baculoviral IAP repeat containing 2 | 0.974 | ||
TRADD | TNFRSF1A-associated via death domain | 0.968 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.935 | Human | |
TRAF2 | TNF receptor-associated factor 2 | 0.922 | Mouse | |
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.878 | Human | |
IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.703 | ||
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.614 | Human | |
TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.599 | ||
TBK1 | TANK-binding kinase 1 | 0.539 | ||
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.493 | ||
TANK | TRAF family member-associated NFKB activator | 0.472 | ||
RNF31 | ring finger protein 31 | 0.461 | ||
BBS10 | Bardet-Biedl syndrome 10 | 0.385 | ||
NLRC4 | NLR family, CARD domain containing 4 | 0.307 | ||
TRAF3 | TNF receptor-associated factor 3 | 0.292 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.285 | ||
RIPK3 | receptor-interacting serine-threonine kinase 3 | 0.277 | ||
CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.255 | ||
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.192 | ||
BAK1 | BCL2-antagonist/killer 1 | 0.175 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.150 | ||
BID | BH3 interacting domain death agonist | 0.148 | ||
TNF | tumor necrosis factor | 0.146 | ||
MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.120 | ||
CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.117 | ||
CLTC | clathrin, heavy chain (Hc) | 0.113 | ||
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.108 | ||
SMCR7 | Smith-Magenis syndrome chromosome region, candidate 7 | 0.108 | ||
DAXX | death-domain associated protein | 0.105 | ||
MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.098 | ||
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.092 | ||
TRAF6 | TNF receptor-associated factor 6 | 0.090 | ||
CYLD | cylindromatosis (turban tumor syndrome) | 0.088 | Mouse | |
HDAC6 | histone deacetylase 6 | 0.079 | ||
SLC25A3 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 | 0.079 | ||
CDC14B | CDC14 cell division cycle 14 homolog B (S. cerevisiae) | 0.076 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.073 | ||
TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.072 | ||
FZR1 | fizzy/cell division cycle 20 related 1 (Drosophila) | 0.068 | ||
RNF144B | ring finger protein 144B | 0.060 | ||
TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | 0.053 | ||
XIAP | X-linked inhibitor of apoptosis | 0.050 | Human | |
BCL2 | B-cell CLL/lymphoma 2 | 0.050 | ||
MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.050 | ||
ZBTB16 | zinc finger and BTB domain containing 16 | 0.045 | ||
THOC3 | THO complex 3 | 0.037 | ||
MAPK1 | mitogen-activated protein kinase 1 | 0.036 | ||
EEF2 | eukaryotic translation elongation factor 2 | 0.034 | ||
SHARPIN | SHANK-associated RH domain interactor | 0.032 | ||
MAP2K7 | mitogen-activated protein kinase kinase 7 | 0.030 | ||
FBXO33 | F-box protein 33 | 0.030 | ||
TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.029 | ||
MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.028 | ||
TRIM21 | tripartite motif containing 21 | 0.028 | ||
PPP6C | protein phosphatase 6, catalytic subunit | 0.026 | ||
C1orf93 | chromosome 1 open reading frame 93 | 0.026 | ||
NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.024 | ||
GRPEL1 | GrpE-like 1, mitochondrial (E. coli) | 0.024 | ||
CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.024 | ||
MYH10 | myosin, heavy chain 10, non-muscle | 0.023 | ||
TRIM38 | tripartite motif containing 38 | 0.023 | ||
USP15 | ubiquitin specific peptidase 15 | 0.023 | ||
DIABLO | diablo, IAP-binding mitochondrial protein | 0.023 | ||
MYH14 | myosin, heavy chain 14, non-muscle | 0.023 | ||
PYCARD | PYD and CARD domain containing | 0.021 | ||
LMO4 | LIM domain only 4 | 0.020 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.020 | ||
HSPA1L | heat shock 70kDa protein 1-like | 0.020 | ||
BECN1 | beclin 1, autophagy related | 0.019 | ||
TKT | transketolase | 0.019 | ||
KIAA1377 | KIAA1377 | 0.019 | ||
TRIM25 | tripartite motif containing 25 | 0.018 | ||
MAPK8 | mitogen-activated protein kinase 8 | 0.018 | Mouse | |
TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.017 | ||
EIF4A1 | eukaryotic translation initiation factor 4A1 | 0.017 | ||
YBX1 | Y box binding protein 1 | 0.016 | Human | |
SLC25A5 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | 0.016 | Human | |
PABPC4 | poly(A) binding protein, cytoplasmic 4 (inducible form) | 0.015 | ||
ARRB2 | arrestin, beta 2 | 0.015 | ||
NOD1 | nucleotide-binding oligomerization domain containing 1 | 0.015 | ||
RNR2 | l-rRNA | 0.015 | ||
PRF1 | perforin 1 (pore forming protein) | 0.015 | ||
CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.014 | Mouse | |
TUBA3C | tubulin, alpha 3c | 0.014 | ||
RPS6KA3 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 | 0.014 | ||
PITPNA | phosphatidylinositol transfer protein, alpha | 0.014 | ||
MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.014 | ||
NLK | nemo-like kinase | 0.014 | ||
FKBP5 | FK506 binding protein 5 | 0.014 | ||
OXA1L | oxidase (cytochrome c) assembly 1-like | 0.013 | ||
JAK2 | Janus kinase 2 | 0.013 | ||
MAVS | mitochondrial antiviral signaling protein | 0.013 | ||
RIPK4 | receptor-interacting serine-threonine kinase 4 | 0.013 | Human | |
MIB1 | mindbomb homolog 1 (Drosophila) | 0.013 | ||
SMCR7L | Smith-Magenis syndrome chromosome region, candidate 7-like | 0.012 | ||
RNF19A | ring finger protein 19A | 0.012 | ||
LRRK2 | leucine-rich repeat kinase 2 | 0.012 | ||
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.012 | ||
MYL6 | myosin, light chain 6, alkali, smooth muscle and non-muscle | 0.011 | ||
RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.011 | Mouse | |
ERP29 | endoplasmic reticulum protein 29 | 0.011 | ||
ATM | ataxia telangiectasia mutated | 0.011 | ||
PIAS4 | protein inhibitor of activated STAT, 4 | 0.010 | ||
FOXO1 | forkhead box O1 | 0.010 | ||
TMOD3 | tropomodulin 3 (ubiquitous) | 0.010 | ||
HSPA9 | heat shock 70kDa protein 9 (mortalin) | 0.010 | ||
GRIP1 | glutamate receptor interacting protein 1 | 0.010 |